Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis
Clinical trial NCT03736161 · COMPLETED
Trial details
- NCT number
- NCT03736161
- Sponsor
- Globe Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2019-09-28
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.